STOCK TITAN

Colgate-Palmolive COO sells 19,938 shares

The COO sold the same 19,938 shares acquired through the option exercise, at prices ranging from $98.585 to $98.97.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Colgate-Palmolive (CL) COO Panagiotis Tsourapas exercised 19,938 stock options on November 4, 2026, at a $76.41 exercise price, acquiring 19,938 common shares. Tsourapas sold 19,938 shares the same day at a weighted average price of $98.7415; sale prices ranged from $98.585 to $98.97. A portion of the sale proceeds was delivered to the issuer for payment of the exercise price and related tax withholding.

The reported post-transaction option balance was 0. Separate indirect common-stock holdings were 4,645 shares by the issuer's 401(k) Plan Trustee and 67,237 shares by a trust; the trust amount includes 2,336 shares previously reported as directly beneficially owned.

Insider Tsourapas Panagiotis
Role COO, CD, EMEA, APac, Skin
Sold 19,938 shs ($1.97M)
Approx. gross sale proceeds $1.97M
Approx. exercise cost $1.52M
Approx. pre-tax spread $445K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F5 19,938 $0.00 $0.00
Exercise Common Stock F1 19,938 $76.41 $1.52M
Sale Common Stock F2, F3 19,938 $98.7415 $1.97M
Holding Common Stock -- -- --
Holding Common Stock F4 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 9,111 shares (Direct); Common Stock — 4,645 shares (Indirect, By Issuer's 401(k) Plan Trustee); Common Stock — 67,237 shares (Indirect, By Trust)
Footnotes (5)
  1. F1. Exercise of stock options awarded under the issuer's incentive compensation plan.
  2. F2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
  3. F3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $98.585 to $98.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. This amount includes 2,336 shares that were previously reported as directly beneficially owned.
  5. F5. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
Stock options exercised 19,938 options November 4, 2026
Exercise price $76.41 per share Options exercised November 4, 2026
Common shares sold 19,938 shares November 4, 2026
Weighted average sale price $98.7415 per share Sale on November 4, 2026
Sale price range $98.585 to $98.97 per share Multiple sale transactions
Post-transaction option position 0 shares Reported after the November 4, 2026 transaction
Indirect common shares by issuer's 401(k) Plan Trustee 4,645 shares Reported November 4, 2026
Indirect common shares by trust 67,237 shares Includes 2,336 shares previously reported as directly beneficially owned
stock options financial
"Exercise of stock options awarded under the issuer's incentive compensation plan."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
incentive compensation plan financial
"stock options awarded under the issuer's incentive compensation plan"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
weighted average price financial
"Weighted average price, as these shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding financial
"payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding"
Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CL shares did the COO exercise and sell?

Panagiotis Tsourapas exercised options for 19,938 shares at a $76.41 exercise price and sold 19,938 shares at a weighted average $98.7415 per share on November 4, 2026. Sale prices ranged from $98.585 to $98.97.

What indirect CL share positions were reported?

The reported indirect positions were 4,645 common shares by the issuer's 401(k) Plan Trustee and 67,237 shares by a trust. The trust amount includes 2,336 shares previously reported as directly beneficially owned.

When did the CL options become exercisable?

The options became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tsourapas Panagiotis

(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NEW YORK 10022

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
COO, CD, EMEA, APac, Skin
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/04/2026M(1)19,938A$76.4129,049D
Common Stock11/04/2026S(2)19,938D$98.7415(3)9,111D
Common Stock4,645IBy Issuer's 401(k) Plan Trustee
Common Stock67,237(4)IBy Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$76.4111/04/2026M(1)19,938 (5)09/10/2028Common Stock19,938$0.00000.0000D
Explanation of Responses:
1. Exercise of stock options awarded under the issuer's incentive compensation plan.
2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $98.585 to $98.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. This amount includes 2,336 shares that were previously reported as directly beneficially owned.
5. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact11/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading